BDSX Q2 2021 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$12M+180.4% YoY

Gross Profit

$5M40.4% margin

Operating Income

-$11M-89.1% margin

Net Income

-$11M-95.9% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

-58.8%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$742,000

Stock-Based Comp.

$539,000

Balance Sheet

Total Assets

$102M

Total Liabilities

$76M

Stockholders' Equity

$26M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$4M	+180.4%
Gross Profit	$5M	$2M	+103.0%
Operating Income	-$11M	-$6M	-88.4%
Net Income	-$11M	-$8M	-37.9%

Revenue Segments

Diagnostic Tests

$11M91%

Service

$1M9%